GlassScriptPhysician profile
Djavid Hadian
NPI 1154392678
$5,131.26
in general payments reported to CMS, 2019-2025
34 companies · $766 in 2025
The $766 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $62.53 · 2021: $115 · 2022: $524 · 2023: $1,350 · 2024: $2,012 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,440 · Travel and Lodging: $498 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,440.43 |
| Travel and Lodging | $497.65 |
| Education | $189.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,256.40 | 2023-2025 | Micra, Symplicity G3, In.Pact Admiral |
| Novartis Pharmaceuticals Corporation | $763.52 | 2019-2025 | |
| Pfizer INC. | $554.52 | 2022-2025 | |
| Boston Scientific Corporation | $429.76 | 2020-2025 | Watchman Access System, Watchman Flx, Latitude Communicator Power Supply |
| Abiomed | $350.55 | 2023-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.51 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $144.93 | 2022-2023 | Verquvo |
| Impulse Dynamics (USA) INC. | $134.90 | 2022-2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $131.48 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $126.13 | 2023 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $120.89 | 2019-2025 | Camzyos, Eliquis |
| Biosense Webster, INC. | $106.08 | 2019-2024 | Carto 3 |
| Biotronik INC. | $100.00 | 2019 | |
| Edwards Lifesciences Corporation | $91.30 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.62 | 2022-2023 | Jardiance |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $67.06 | 2024 | Arcalyst |
| Abbott Laboratories | $60.77 | 2022-2024 | Cardiomems |
| Shockwave Medical, INC | $54.22 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Imperative Care, INC | $45.77 | 2025 | Prodigy Catheter, Symphony Catheter |
| W. L. Gore & Associates, INC. | $42.65 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Astrazeneca Pharmaceuticals LP | $41.87 | 2022 | |
| Baxter Healthcare | $39.86 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $32.13 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $28.22 | 2023 | Inpefa |
| Sanofi-Aventis U.S. LLC | $20.83 | 2022 | |
| Amgen INC. | $20.67 | 2023 | Repatha |
| Teleflex LLC | $20.46 | 2025 | Vascband |
| Altathera Pharmaceuticals LLC | $18.68 | 2024 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals, LTD. | $18.16 | 2023 | Arcalyst |
| Terumo Medical Corporation | $17.31 | 2022 | |
| Cook Medical LLC | $14.21 | 2025 | Resonance |
| Kowa Pharmaceuticals America, INC. | $14.04 | 2023 | Livalo |
| Cardiva Medical, INC. | $13.33 | 2021 | |
| Elutia, INC. | $9.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Djavid Hadian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.